.png){kind=logo}
NeuroFlow is a digital health company combining workflow automation, patient engagement tools, and applied AI to promote behavioral health integration in all care settings. NeuroFlow's suite of HIPAA-compliant, cloud-based tools simplify remote patient monitoring, improve risk stratification, and facilitate collaborative, measurement-based care. With NeuroFlow, providers, health systems, and health plans providers can bridge the gap between mental and physical health to improve outcomes, increase wellness and reduce the cost of care.
NeuroFlow co-founders Chris Molaro and Adam Pardes first crossed paths as graduate students at the University of Pennsylvania in 2016. Molaro, having completed a five-year tour as a platoon officer in the Army, developed a personal mission to improve the mental health offerings for veterans and civilians alike. The key to transforming that calling into a viable business came from discovering a way to effectively utilize technology to monitor and manage behavioral health both from a provider and patient perspective.
Today, the platform is leveraged by over 140 organizations including Jefferson Health, the VA, and more to help 20,000+ patients manage and improve their mental wellness.
Chris Molaro, named under the top 10 transformational leader of healthcare and a finalist for EY's 'Entrepreneur of the Year', is the CEO and co-founder of NeuroFlow and on a mission to bridge the gap between mental and physical health.
After five years of service in the Army, Molaro returned home and witnessed firsthand the devastating toll of an error-prone and inefficient mental health system in the United States. He soon channeled his passion and energy into launching and running the veteran literacy non-profit called 'Things We Read'. Afterward, Chris went on to complete his MBA at The Wharton School at the University of Pennsylvania and met his eventual co-founder and COO Adam Pardes, a bioengineering PhD candidate. The two soon founded and launched NeuroFlow.
Chris regularly speaks at numerous healthcare events, panels, and summits. Additionally, Chris has been a featured speaker for the American Psychological Association, Partners Health World Innovation Forum, interviewed on SiriusXM radio, NBC10, and in multiple healthcare and business-focused podcasts, profiled in multiple publications, guest lectured at Penn's Engineering school, and provided his expert opinion on CMS policies.
Technology can never completely replace some of the critical, human elements required in truly collaborative and integrated care. Instead, technologies like NeuroFlow can act as a clinical support tool to automate, digitize and streamline a lot of manual work already being done by practitioners to address and treat mental health conditions. Moreover, thoughtful, clinically relevant applications of data science such as risk stratification models and natural language processing help to deliver a transformative behavioral health experience for the NeuroFlow's clinical partners, allowing them to easily and proactively identify patients with the highest needs and conduct measurement-based care remotely and continuously.
What sets NeuroFlow apart from the competition is its ability to transform and digitize the integration of behavioral health from the moment a patient meets with their provider all the way to a provider being reimbursed. The company has combined elements like gamification, behavioral economics, and more from leading consumer apps with key processes and workflows found in provider and facing tools and added in an underlying focus on data science to ultimately carve out a strategic advantage to become the market leader in integrated behavioral health. Additionally, NeuroFlow's strategic and integration partnerships with organizations like Redox, athenahealth, Genomind, GoodTherapy, PsycHub and more support its mission to use technology to close the gap between mental and physical health.
NeuroFlow has been recognized in multiple publications, won the Health 2.0 VentureConnect competition at HIMSS, and received the designation of top mental health startup from MedTech Boston. The company was recently named as a finalist for the best mental health tech company for the UCSF Digital Health Awards and named the best overall mental health solution in the 2019 Medtech Breakthrough Awards. NeuroFlow had also been named a semi-finalist for Startup of the Year, was named the top presenting company at MedCity INVEST Population Health, and received the designation for Technological Excellence from the Philadelphia Chamber of Commerce.
Chris and the NeuroFlow team believe personalized medicine is no longer a fantasy; it's being realized in all aspects of the healthcare continuum. As it relates to mental health, the increased adoption of technology, combined with ever increasing pateint expectations for delivery of care of technology will help to advance efforts for providers looking to take a more personalized, data-driven approach to care and treating the whole patient.
Fortunately, the growing awareness efforts of nonprofits, celebrities, advocacy groups, and healthcare organizations are helping to normalize and bring awareness to the conversation around mental health. Meanwhile, technological developments are leading to new solutions and better care for those living with behavioral health disorders, pairing patients with the most appropriate resources, from tools leveraging clinically validated self-help methodologies to digital connections with a range of medical providers. "Heightened awareness and digital advances beget healthier, more frequent discussions around treatments and solutions for the millions needing treatment and support," said Molaro. "We're excited about leading the charge in leveraging AI and data to help address the challenges of access and engagement that have led to a disjointed, and inefficient approach of treating mental health separately from physical health."
Join our WhatsApp Channel to get the latest news, exclusives and videos on WhatsApp
_____________
Disclaimer: Analytics Insight does not provide financial advice or guidance. Also note that the cryptocurrencies mentioned/listed on the website could potentially be scams, i.e. designed to induce you to invest financial resources that may be lost forever and not be recoverable once investments are made. You are responsible for conducting your own research (DYOR) before making any investments. Read more here.
